Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Theiler-Schwetz, V; Schlager, H; Obermayer-Pietsch, B; Stojakovic, T; Fauler, G; Fickert, P; Zollner, G.
Hypercortisolism in patients with cholestasis is associated with disease severity.
BMC Gastroenterol. 2021; 21(1):460 Doi: 10.1186/s12876-021-02045-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Theiler-Schwetz Verena
Zollner Gernot
Co-Autor*innen der Med Uni Graz
Fauler Günter
Fickert Peter
Obermayer-Pietsch Barbara
Schlager Hansjörg
Stojakovic Tatjana
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), but supraphysiological bile acid levels were found to stimulate steroidogenesis independent of FXR and TGR5. Our previous experimental findings revealed that mice fed bile acids or subjected to common bile duct ligation develop hypercortisolemia. We thus aimed to assess adrenal gland function in patients with cholestasis. METHODS: Adrenal gland function was assessed in 36 patients with cholestasis and in 32 patients without cholestasis by measuring total serum cortisol, adrenocorticotropic hormone (ACTH), as well as the increase of cortisol 20 and 30 min after administration of 1 µg of ACTH. Bile acid levels and bile acid pool composition were determined by high-resolution mass spectrometry. RESULTS: Patients with cholestasis per definition had markedly elevated levels of alkaline phosphatase (AP), bilirubin and serum bile acids. Baseline cortisol and maximum cortisol after ACTH stimulation were significantly higher in patients with cholestasis compared to controls. Increase of cortisol after ACTH stimulation and ACTH did not differ. In the cholestasis group, baseline cortisol correlated with bilirubin but not with AP, total serum bile acids and levels of conjugated and unconjugated bile acid species. Patients with duration of cholestasis < 6 months (n = 30) had significantly higher baseline cortisol levels than those with long standing cholestasis (> 6 months), together with higher bilirubin levels. CONCLUSIONS: We find no evidence of adrenal insufficiency in non-cirrhotic patients with cholestasis. In contrast, patients with cholestasis show hypercortisolism associated with disease severity as mirrored by levels of bilirubin. Lack of ACTH increase in cholestasis suggests a direct effect of cholestasis on adrenals and not on the pituitary gland. Further studies are needed to elucidate the mechanism of cortisol elevation in patients with cholestasis and its clinical significance.
Find related publications in this database (using NLM MeSH Indexing)
Animals - administration & dosage
Cholestasis - complications
Cushing Syndrome - complications
Humans - administration & dosage
Hydrocortisone - administration & dosage
Hypothalamo-Hypophyseal System - administration & dosage
Mice - administration & dosage
Pituitary-Adrenal System - administration & dosage
Severity of Illness Index - administration & dosage

Find related publications in this database (Keywords)
Hypothalamic-pituitary-adrenal axis (HPA axis)
Adrenal gland
Bile acids
Cholestasis
Bilirubin
Cortisol
© Med Uni Graz Impressum